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The effects of a robot-assisted arm training plus hand functional electrical stimulation on 1 
recovery after stroke: a randomized clinical trial.  2 
Abstract 3 
Objective: To compare the effects of unilateral, proximal arm robot-assisted therapy combined 4 
with hand functional electrical stimulation to intesive conventional therapy for restoring arm 5 
function in subacute stroke survivors.  6 
Design: This was a single blinded, randomized controlled trial. Setting: Inpatient Rehabilitation 7 
University Hospital. Participants: Forty patients diagnosed with ischemic stroke (time since stroke 8 
<8 weeks) and upper limb impairment were enrolled. Interventions: Participants randomized to the 9 
experimental group received 30 sessions (5 sessions/week) of robot-assisted arm therapy and hand 10 
functional electrical stimulation (RAT + FES). Participants randomized to the control group 11 
received a time-matched intensive conventional therapy (ICT). Main outcome measures: The 12 
primary outcome was arm motor recovery measured with the Fugl-Meyer Motor Assessment. 13 
Secondary outcomes included motor function, arm spasticity and activities of daily living. 14 
Measurements were performed at baseline, after 3 weeks, at the end of treatment and at 6-month 15 
follow-up. Presence of motor evoked potentials (MEPs) was also measured at baseline. 16 
Results: Both groups significantly improved all outcome measure  except for spasticity without 17 
differences between groups. Patients with moderate impairment and presence of MEPs who 18 
underwent early rehabilitation (<30 days post stroke) demonstrated the greatest clinical 19 
improvements. 20 
Conclusions: A robot-assisted arm training plus hand functional electrical stimulation was no more 21 
effective than intensive conventional arm training. However, at the same level of arm impairment 22 
and corticospinal tract integrity, it induced a higher level of arm recovery. 23 
 24 
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 26 
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Abbreviations:  27 
ANOVA: analysis of variance 28 
BBT: Box and Block Test 29 
BI: Barthel Index 30 
FES: functional electrical stimulation 31 
FMA-UE: Fugl-Meyer Assessment – Upper Extremity 32 
ICT: intensive conventional therapy 33 
MAS: Modified Ashworth Scale 34 
MCID: minimal clinically important difference 35 
MEPs: motor-evoked potentials 36 
OP:  opponent muscle 37 
OSP: optimal scalp position 38 
RAT: robot-assisted therapy 39 
rMT: resting motor threshold 40 
TMS: transcranial magnetic stimulation 41 
WMFT: Wolf Motor Function Test 42 
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INTRODUCTION 43 
The first 10 to 12 weeks post-stroke represent the im window when most of the functional arm 44 
recovery occurs.1,2 Recently, stroke rehabilitation has recognized the importance of a timely 45 
intensive, task specific therapy to foster motor recovery;2,3 however evidence supporting the 46 
superiority of one intervention over another is very scarce in subacute stroke clinical trials,4 47 
probably due to the spontaneous functional recovery that acts as prime confounder in this 48 
rehabilitation phase. The use of technology-aided interventions, such as robotics and electrical 49 
stimulation devices has been rapidly introduced into clinical settings with the aim of increasing 50 
repetitions of motor tasks and promoting the restorati n of motor function after stroke. Both arm 51 
robotics and hand FES devices have been previously tested in stroke survivors, providing mixed 52 
results.5–9 Arm robotics failed to demonstrate its superiority on task-oriented training, usual therapy 53 
or even if applied at a very early stage.5–7 A more comprehensive recommendation was given in a 54 
recent update of the Cochrane review concluding that arm robotics was effective in increasing 55 
activities of daily living, even in the subacute stroke subgroup.10 Jonsdottir et al.8 reported a 56 
beneficial effect of FES in addition to a task-oriented approach and it seems to improve activities of 57 
daily living in the subacute phase after stroke.9 Nevertheless, a combination of the two interventions 58 
using commercialized devices had not been tested so far. 59 
Considering the positive effects on motor recovery of arm robotics and hand FES, we explored the 60 
effects of the combination of a shoulder-elbow robotic device11 with a hand FES neuroprosthesis on 61 
the whole arm recovery.12,13 The primary aim of this study was to test the hypothesis that a proximal 62 
arm robot-assisted therapy with the additional use of hand functional electrical stimulation (RAT + 63 
FES) during the subacute phase of rehabilitation could have higher benefit, compared with intensive 64 
conventional therapy (ICT) alone, in arm and hand function in subacute stroke patients. Moreover, 65 




This was a prospective, randomized, single-blinded, control study. This trial was approved by local 69 
Ethics Committee and a written consent was provided. All procedures were conducted according to 70 
the ethical standards of the Declaration of Helsinki. The trial protocol has been registered on 71 
ClinicalTrials.gov (NCT02267798). The data that support the findings of this study are available 72 
from the corresponding author upon reasonable request. Inclusion criteria were: males and females, 73 
aged 18-80 years with diagnosis of first, single unilateral ischemic stroke verified by brain imaging 74 
<8 weeks. To be enrolled in the study patients had to have an upper limb motor impairment defined 75 
by an upper extremity score >11 and <55 on the Fugl-Meyer Assessment (FMA-UE). Patients were 76 
excluded if they presented with neurological conditions in addition to stroke that may affect motor 77 
function, other medical conditions likely to interfe with the ability to safely complete the study 78 
protocol, impaired cognitive functioning (score <21 on the Mini Mental Status Examination), or 79 
severe upper-limb pain defined  as  >7  on the Visual Analogue Scale. Participants were randomized 80 
to the two groups through a block randomization approach. The randomization scheme was 81 
generated using the website http://www.randomization.c m. The random list was managed by an 82 
administrator external to the research groups to prevent selection bias.  83 
The experimental group received 1 hour and 40 minutes of hand FES+ RAT for each session (5 84 
times/week over 6 weeks); the control group received th  same amount of conventional therapy.  85 
The primary outcome for this study was to detect arm motor recovery. We chose the Fugl-Meyer 86 
motor Assessment score, which is the most sensitive to therapeutic change early after stroke in 87 
stroke patients with arm paresis.14–16 The score ranges from 0-66. Moreover, arm motor function 88 
was tested with the Wolf Motor Function Test (WMFT) that encompasses single or multiple joint 89 
movements and functional tasks and that has been succe sfully used in subacute and moderate to 90 
severely affected stroke patients.17–20 Gross motor function was evaluated using the Box and Block 91 
Test (BBT) where the number of blocks that can be transported from one compartment of a box to 92 
another compartment within 1 minute is counted.21 Arm spasticity was assessed with the Modified 93 
Ashworth Scale (MAS).22 Furthermore, ADL independency was measured with the Barthel Index 94 
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(BI).23 All patients were evaluated before intervention (T0), after 3 weeks (T1), at the end of 95 
treatment (T2) and at 6-month follow-up (T3) by an investigator blinded with regards to the 96 
treatment group.  97 
The presence/absence of TMS-induced motor-evoked potentials (MEPs) was measured as a 98 
possible prognostic factor of recovery at baseline. Focal TMS was performed by means of a 70-mm 99 
figure-of-8 stimulation coil (standard Magstim plastic-covered coil), connected to a Magstim Bistim 100 
(The Magstim Company, Carmarthenshire, Wales, UK)a, producing a maximum output of 2 T at the 101 
coil surface (pulse duration, 250 ls; rise time, 60 ls). The resting motor threshold (rMT), defined as 102 
the lowest stimulus intensity able to evoke 5 of 10 MEPs with an amplitude of at least 50 µV, was 103 
determined by holding the stimulation coil over theoptimal scalp position (OSP), defined as the 104 
position from which MEPs with maximal amplitude were recorded for opponent (OP) muscle. The 105 
patient was classified as MEP+ if MEPs were observed with a consistent latency in response to at 106 
least 5 stimuli, with OP latencies ≈ 20 – 40 ms; MEP- if MEPs were not observed at rest with 100% 107 
maximum stimulator intensity.  108 
The experimental group received 1 hour and 40 minutes of arm rehabilitation. Specifically, a 40 109 
minute-session of hand FES was delivered through a battery-powered programmable stimulator and 110 
a forearm-wrist-hand orthosis containing 5 electrodes positioned to provide reliable activation of the111 
following muscles: extensor digitorum communis, extensor pollicis brevis, flexor pollicis longus, 112 
flexor digitorum superficialis, and thenar muscles (H200, Bioness, CA)b. The intensity of 113 
stimulation was set to a level that provided comfortable and consistent activation of the extensor 114 
and flexor muscles to achieve whole hand opening and fu ctional grasping. Participants were 115 
instructed to coordinate their actions with the pre-timed stimulation patterns programmed in the 116 
device so as to synchronize the user’s intention with FES assistance. Although the stimulation 117 
cycles were fixed, participants needed to engage actively in the tasks to produce the synergistic 118 
muscle actions throughout the upper limb required for e fective task performance. The therapist set 119 
up activities to involve each subject in functional exercises specific to their personal needs, such as 120 
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reaching, grasping, holding and releasing or daily activities with upper limb engagement. The 121 
voluntary contraction during electrical stimulation increases motor cortical excitability in the 122 
agonist muscle.24 After FES training, patients received 60 minutes of RAT with an end-effector 123 
device (Reo Therapy System, Motorika Medical Ltd, Israel)c which focused on repetitive tasks that 124 
incorporate multidirectional reaching actions. In this robot-assisted therapy a robot manipulator 125 
applied forces to the paretic arm during goal-directed movements. During the session the patient's 126 
affected hand was placed on or strapped onto a robotic arm and she/he was instructed to either 127 
actively reach predefined reach points, or to be guided while the robotic arm led the arm towards 128 
these reach points.  129 
The control group received the same time of conventional arm therapy (100 minutes). Specific 130 
exercises for the affected upper limb included active, passive and sensory exercises or functional 131 
tasks.  132 
In addition to arm rehabilitation, all patients received multidisciplinary rehabilitation based on an 133 
individualized approach. 134 
Baseline characteristics were reported as mean and st ard deviation, median and inter-quartile 135 
range or frequency and percentage, according to variables distribution and compared among groups 136 
to confirm the quality of randomization, using unpaired t-test, Wilcoxon-Mann-Whitney test or 137 
Pearson’s Chi-Squared test, as appropriate. To investigate time effects (T0, T1, T2 and T3) within 138 
groups we applied both Analysis of variance (ANOVA) and the alternative non-parametric 139 
Friedman test as a confirmatory analysis; results were reported as mean and 95% CI. To underline 140 
between-group differences, unpaired t-tests were performed. Since stroke encompasses a wide 141 
spectrum of characteristics, linear models were used to analyse the effect of several factors (age, 142 
sex, stroke type, affected hemisphere, comorbidities, cognitive and sensory deficits, stroke onset, 143 
MEPs presence/absence and arm impairment at baseline) on motor recovery. An intention-to-treat 144 
analysis was carried out on all outcome measures, handling missing data with the last observation 145 
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carried forward approach. Statistical analysis was performed using STATA 13 (StataCorp, College 146 
Station, TX) software. Significance was recognized when p < 0.05. 147 
We were interested in detecting a between-group difference equal to the minimal clinically 148 
important difference (MCID) value for FMA-UE which is 9 ± 8.8 points given a power of 80% and 149 
α of 5%.25 Therefore, the sample size needed resulted of at least 34 patients (17 in each group); 150 
however, an increase of 20% to 40 patients was adopted to account for possible drops-out. 151 
RESULTS 152 
391 consecutive patients with ischemic stroke were sc ened between January 2014 and September 153 
2016 and 40 were enrolled in the study (median age 68 (58-73), 61.5% males, 37 (21-60) median 154 
days from stroke onset). One subject in the RAT + FES group did not receive the allocated 155 
treatment due to a post-randomization drop-out, whereas one patient in the ICT group did not 156 
receive the allocated treatment due to an organizational error. All participants concluded the 157 
rehabilitation protocols, except for a subject in the RAT + FES group who withdrew for medical 158 
issues. The 17.5% (5 in the RAT + FES group and 2 in the ICT group) did not return to the hospital 159 
for the 6-month follow-up for personal reasons (overall attrition rate 22.5 %). The study flow 160 
diagram is reported in Figure 1.  161 
[INSERT FIGURE 1 ABOUT HERE] 162 
The two groups were similar in demographic and clinical characteristics, as summarized in Table 1 163 
and 2. 164 
[INSERT TABLE 1 and 2 ABOUT HERE] 165 
Both groups significantly improved all outcome measure  (FMA-UE, BBT, WMFT, BI) over time 166 
(p< 0.001) except for spasticity (MAS). The effects were highlighted since T1 (mid-treatment 167 
assessment). Results were reported in Table 3.  168 
[INSERT TABLE 3 ABOUT HERE] 169 
Between-group differences were not found for any variables, leading to the conclusion that RAT + 170 
FES was not superior than ICT in increasing motor recovery after stroke in a subacute phase.  171 
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We run a linear regression model to analyse the influe ce of several demographic or clinical factors 172 
on FM-UE improvement after rehabilitation or on FM-UE at 6-month follow-up.  173 
The first one was predicted by stroke onset (β = -0.15; p = 0.005) and FMA-UE at baseline (β = -174 
0.18; p = 0.05), whereas arm motor function at 6 months was influenced by stroke onset (β = -0.30; 175 
p = 0.013), FM-UE at baseline (β = 1.0; p < 0.001) and MEPs (β = 13.47; 0.036). Given that arm 176 
severity at baseline and time since stroke can be considered as possible confounders, we categorized 177 
our sample into subgroups according to these variables: ≤ 30 days since stroke (early rehabilitation) 178 
or > 30 days since stroke (late rehabilitation) and≤ 21 points FM-UE (severe), > 21 points FM-UE 179 
(moderate to mild).26 See Table 4 and Figure 2. 180 
[INSERT TABLE 4 ABOUT HERE] 181 
[INSERT FIGURE 2 ABOUT HERE] 182 
Moderate and early rehabilitation subgroups achieved th  greatest clinical improvements after 183 
rehabilitation compared to the severe and late rehabilitation subgroups. Specifically, it was 184 
statistically significant in the ICT group for severity (+ 15.5 FM-UE points in the moderate group 185 
compared to + 4.4 FM-UE points in the severe group; p = 0.02) and in the RAT + FES group for 186 
time since stroke (+13.7 FM-UE points in the early rehabilitation group compared to + 6.3 FM-UE 187 
points in the late rehabilitation group; p = 0.01).  188 
Our analysis revealed that only 15.79% of the patients who were enrolled within 30 days after 189 
stroke had a severe arm paresis, compared with 47.62% who started arm rehabilitation after 30 days 190 
post stroke (Chi2 4.60; p = 0.032). Thus, severity and time since stroke were not independent 191 
factors. To better explore the effects of treatments, arm severity and time since stroke on arm 192 
recovery, a mixed-effects linear model was run, showing that only arm severity significantly 193 
influenced FM-UE score (β = -22.89; p < 0.0001) with a positive interaction severity*time (at T2 β 194 
= - 5.96; p = 0.02), whereas neither time since stroke nor treatment reached statistical significance. 195 
See Figure 3. 196 
[INSERT FIGURE 3 ABOUT HERE] 197 
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We found that, in addition to severity, treatment ad MEPs significantly influenced arm motor 198 
recovery over time. Patients who were allocated to RAT + FES reached a higher level of arm 199 
recovery (β= + 5.93; p = 0.016) compared to ICT, considering same impairment level and MEPs; 200 
whereas patients with MEP+ obtained a greater arm recovery at 6-month follow-up (β=4.35; 201 
p=0.011). See Figure 4. 202 
[INSERT FIGURE 4 ABOUT HERE] 203 
We observed the amount of practice during therapy sessions (n=35) in a convenience sample. 204 
During ICT (n=16) the amount of movement practice was observed and categorized according to 205 
Lang et al.27 into active exercise, passive exercise, sensory and functional. We reported 376.06 ± 206 
36.12 repetitions /each ICT session with 55.70% of functional tasks (209.5 ± 24.8) compared to 207 
794.68 ± 318.50 repetitions/each RAT + FES session (p<0.001). The session consisted of 630.47 ± 208 
284.90 RAT repetitions and 164.21 ± 68.34 FES repetitions.  209 
DISCUSSION 210 
This clinical trial failed to demonstrate the superiority of an arm robotics plus hand FES training on 211 
a time-matched ICT in a subacute stroke population. B th groups equally improved their arm 212 
impairment, arm function and activities of daily living after an intensive arm rehabilitation and 213 
reached further gains at 6-month follow-up. Arm motor recovery, measured with the FMA-UE, was 214 
clinically significant at the end of both treatments, considering an MCID of 9-10 points. Similarly, 215 
arm function improvement measured with the WMFT Function score reached the MCID of 1.2 216 
points in both groups after 15 sessions.28 The independence in activities of daily living, monit red 217 
with the BI, clinically improved after 15 sessions, considering a MCID value of 1.85 points.23 218 
This trial confirmed the potential role of several factors (intensity, time, arm severity and integrity 219 
of the corticospinal tract) on arm motor recovery after stroke, outlining potential recovery 220 
trajectories that can be modulated by intensive arm rehabilitation. Regarding intensity, the proposed 221 
interventions were both more intense (~200 repetitions/session in ICT and ~ 700 repetitions/session 222 
in RAT + FES group) compared to usual arm rehabilittion reported by Lang at al. who observed a 223 
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mean of 32 functional repetitions during a usual physiotherapy session.27 However, a dose-response 224 
effect of task-specific upper limb training in chronic stroke patients has not been proved.29  225 
The first 30 days after stroke represent a critical time-window for starting rehabilitation, when the 226 
interaction between treatment and spontaneous recovery process can be more effective;2 however, 227 
only 6% of stroke motor rehabilitation RCTs have enrolled all patients during the first month after 228 
stroke.30 In our trial we enrolled patients within 8 weeks after stroke with a mean of 37 days. An 229 
association between time since stroke and arm motor rec very has been highlighted, confirming the 230 
importance of early rehabilitation for stroke outcome. 231 
Initial arm severity is the most important predictor of arm recovery after stroke and the majority of 232 
stroke patients shows a fixed arm proportional recov ry of about 78%.31,32 Patients who present an 233 
initial severe paresis usually do not follow this rule and, for these patients, the study of the integrity 234 
of the corticospinal tract by TMS in the first days after stroke can be useful to predict recovery.33–35 235 
In this scenario, the role of arm rehabilitation might be that of accelerating and optimizing this time-236 
dependent, dynamic process, through a modulation of the spontaneous recovery mechanisms.4,36  237 
In our study, we confirmed the association between baseline arm severity and functional recovery, 238 
even if baseline assessment was not done in the first few days after the stroke, as studies of stroke 239 
recovery recommended.31,35 The mixed-effects linear model outlined that given a fixed level of arm 240 
severity and integrity of the corticospinal tract, the RAT + FES group presented a higher arm 241 
recovery over time, suggesting a potential role of these interventions to promote recovery during 242 
rehabilitation. 243 
Study Limitations 244 
In this 3-year study we enrolled subacute ischaemic stroke survivors with arm paresis defined by a 245 
FMA-UE score of 12-54, within 8 weeks from stroke. With this inclusion criteria, we had a 246 
recruitment rate of 10% which is in line with other subacute stroke trials;37,38 however a low 247 
proportion of patients recruited limits the generalizability of results to the entire stroke population. 248 
Even though we reached the predetermined sample size, our hypothesis on groups difference was 249 
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too optimistic and further analyses on bigger samples are needed. Another limit is that our two 250 
intensive interventions were time-matched, instead of ose-matched. Both groups received more 251 
therapy compared to usual arm therapy, however a significant difference was highlighted in favor of 252 
the experimental group.27 However, it is possible that more than repetitions, the quality and salience 253 
of movements trained are essential to induce motor recovery. Finally, a potential reason for the 254 
overall negative results, is that, at this stage, we characterized our sample only based on clinical 255 
outcomes and the integrity of the corticospinal tract. Including markers of biology, imaging, 256 
neurophysiology or a combination of these might improve knowledge on the effects of arm 257 
rehabilitation on stroke recovery.39  258 
CONCLUSION 259 
An intensive arm training that combined RAT and hand-FES, seems to not be superior to a time-260 
matched intensive conventional arm training, even though people who received RAT + FES, at the 261 
same level of arm impairment and corticospinal tract integrity, reached a higher level of arm 262 
recovery.  263 
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Figure 1: CONSORT flow diagram. 386 
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Figure 2: Scatterplots showing effects of stroke onset  and arm severity at baseline on arm recovery 387 
after rehabilitation (T0-T2) and at follow-up (T3)  (♦ and dotted line for ICT group; ○ and 388 
continuous line for RAT + FES group). 389 
Figure 3: predicted arm recovery (FM-UE) as a function of severity and stroke onset (♦ and 390 
continuous line for RAT+FES moderate early, ♦ and dotted line for ICT moderate early; ▲ and 391 
continuous line for RAT+FES moderate late, ▲ and dotted line for ICT moderate late; ■ and 392 
continuous line for RAT+FES severe early, ■ and dotted line for ICT severe early, ● and 393 
continuous line for RAT+FES severe late, ● and dotted line for ICT severe late). 394 
Early = ≤ 30 days since stroke; late = > 30 days since stroke; moderate = > 21 points FM-UE; 395 
severe = ≤ 21 points FM-UE 26 396 
Figure 4: predicted arm recovery (FM-UE) as a function of corticospinal tract integrity and severity  397 
(♦ and continuous line for RAT+FES moderate MEP+, ♦ and dotted line for RAT+FES moderate 398 
MEP-; ▲ and continuous line for ICT moderate MEP+, ▲ and dotted line for ICT moderate MEP-; 399 
■ and continuous line for RAT+FES severe MEP+, ■ and dotted line for RAT+FES severe MEP-, ● 400 
and continuous line for ICT severe MEP+, ● and dotted line for ICT severe MEP-). 401 
Moderate = > 21 points FM-UE; severe = ≤ 21 points FM-UE 26 402 
Table 1. Participants Characteristics at Baseline. 
 RAT + FES  
(n = 19) 
ICT  
(n = 20) 
Total 
(n = 39) 
p 
Age, years* 68 (56-71) 68 (58.5-73) 68 (58-73) 0.715 
Gender, no. male (%) 12 (63.2) 12 (60.0) 24 (61.5) 0.839 
Type of stroke     
Subcortical, no. (%) 9 (47.4) 10 (50.0) 19 (48.7) 0.344 
Cortical, no. (%) 6 (31.6) 9 (45.0) 15 (38.5)  
Brainstem, no. (%) 4 (21.0) 1 (5.0) 5 (12.8)  
Time since stroke, days* 39 (21-62) 32.5 (20-51) 37 (21-60) 0.574 
Affected hemisphere, no. left (%) 13 (68.4) 14 (70.0) 27 (69.2) 0.915 
Sensory impairment, no. (%) 4 (25.0) 5 (27.8) 9 (26.5) 0.855 
Cognitive impairment, no. (%) 4 (23.5) 6 (35.3) 10 (29.4) 0.452 
Comorbidities, no. * 1.5 (1-3) 2 (1-3) 2 (1-3) 0.384 
MEPS n (%)† 7 (50.0) 9 (60.0) 16 (55.2) 0.588 
Abbreviations: RAT + FES, Robot Arm Training + Functional Electrical Stimulation; ICT, Intensive 
Coventional Therapy; p, level of significance. 
*Median (interquartile range). 
† FDI-TMS was performed in 14/19 RAT + FES subjects and 15/20 ICT subjects  
 
Table 2. Baseline characteristics of subacute ischemic stroke who received RAT + FES or ICT. 
 RAT + FES  
(n = 19) 
ICT  
(n = 20) 
Total 
(n = 39) 
p 
Fugl-Meyer Assessment Upper Extremity (FMA-UE)     
Total score * 28.8 ± 13.3 31.4 ± 12.3 30.1 ± 12.7 0.529 
Proximal score* 17.4 ± 8.4 20.4 ± 7.1 18.9 ± 7.8 0.246 
Distal score* 7.8 ± 5.7 7.6 ± 6.5 7.7 ± 6.0 0.902 
Impairment level     
Mild (score 66-49) no. (%) 1 (5.3) 1 (5.0) 2 (5.1)  
Moderate (score 48-22) no. (%) 10 (52.6) 14 (70.0) 24 (61.5)  
Severe (score 21-0) no. (%) 8 (42.1) 5 (25.0) 13 (33.3)  
Modified Ashworth Scale, total score † 1 (1-4) 1.75 (1-2.5) 1.5 (1-3) 0.819 
Box and Block Test affected arm, total score † 7 (0-20) 6 (0-18.5) 7 (0-20) 0.728 
Wolf Motor Function Test     
Functional Ability Scale score * 31.9 ± 19.6 31.2 ± 22.1 31.5 ± 20.6 0.918 
Task rate ‡, no. * 12.5 ± 10.4 17.3 ± 12.3 15.0 ± 11.5 0.190 
Barthel Index, total score b 80 (40-90) 75 (52.5-90) 75 (45-90) 0.724 
 
Abbreviations: RAT + FES, Robot Arm Training + Functional Electrical Stimulation; ICT, Intensive Coventional Therapy; p, level of significance. 
* Mean (standard deviation). 
†Median (interquartile range) 
‡ Task rate = 60(s)/Performance Time (s)28 
Table 3. Effects of RAT+FES or ICT on primary and secondary outcome measures reported as mean (95% CI). 
  ∆ T0-T1 ∆ T0-T2 ∆ T0-T3 p 
 FMA-UE, total score RAT + FES 7.0 (4.0-10.0) 9.8 (6.6-13.0) 13.2 (8.3-18.1) <0.001 
 ICT 7.9 (4.9-10.8) 12.8 (9.2-16.3) 16.5 (11.9-21.1) <0.001 
 p 0.674 0.200 0.308  
FMA-UE, proximal score RAT + FES 3.3 (1.2-5.4) 4.8 (2.9-6.8) 6.6 (3.9-9.3) <0.001 
 ICT 3.7 (2.1-5.3) 5.9 (4.1-7.7) 6.5 (4.3-8.7) <0.001 
 p 0.760 0.404 0.937  
FMA-UE distal score RAT + FES 3.5 (1.9-5.2) 4.5 (2.7-6.3) 5.1 (3.1-7.1) <0.001 
 ICT 5.2 (3.0-7.4) 5.7 (3.7-7.7) 7 (4.7-9.3) <0.001 
 p 0.220 0.351 0.197  
MAS, total score RAT + FES 0.13 (-0.88-1.14) -0.24 (-1.41-0.93) 0.37 (-0.95-1.69) 0.651 
 ICT -0.30 (-0.89-0.29) -0.60 (-1.18- -0.02) -0.78 (-1.55- -0.01) 0.106 
 p 0.446 0.564 0.127  
BBT affected arm, total score RAT + FES 7.4 (1.7-13.0) 8.4 (3.2-13.6) 10.5 (4.6-16.5) <0.001 
 ICT 7.0 (3.1-10.8) 10.3 (5.2-15.4) 13.6 (7.6-19.5) <0.001 
 p 0.898 0.590 0.456  
WMFT Functional Ability Scale score RAT + FES 8.0 (3.5-12.5) 11.2 (5.2-17.2) 15.7 (7.3-24.1) <0.001 
 ICT 11.9 (7.0-16.8) 17.1 (11.4-22.8) 23.6 (16.1-31.1) <0.001 
 p 0.232 0.142 0.150  
WMFT Task rate*, no. RAT + FES 7.7 (3.6-11.8) 10.4 (5.5-15.3) 12.4 (5.6-19.1) <0.001 
 ICT 6.6 (3.3-9.9) 10.2 (5.1-15.2) 13.6 (7.8-19.4) <0.001 
 p 0.669 0.945 0.767  
BI, total score RAT + FES 10.5 (3.5-17.6) 16.1 (6.7-25.4) 22.6 (12.1-33.1) <0.001 
 ICT 9.8 (2.9-16.6) 19.3 (12.0-26.5) 24.3 (13.0-35.5) <0.001 
 p 0.869 0.572 0.828  
Abbreviations: RAT + FES, Robot Arm Training + Functional Electrical Stimulation; ICT, Intensive Coventional Therapy; T0, assessment before 
treatment; T1, assessment after 3 weeks of treatment; T2, assessment after the end of treatment; T3, assessment at 6 months follow-up; p, level of 
significance over time (Friedman Test); FMA-UE, Fugl-Meyer Assessment Upper Extremity; MAS, Modified Ashworth Scale; BBT, Box and 
Block Test; WMFT, Wolf Motor Function Test; MAL, Motor Activity Log; BI, Barthel Index;* Task rate = 60(s)/Performance Time (s) 28 
Table 4. Effects of RAT + FES or ICT on primary outcome in subgroups stratified for arm 
impairment and time since stroke reported as mean (standard error). 
 Impairment level  Time since stroke  
Moderatea Severeb p ≤ 30 days > 30 days p 
RAT + FES (n=11) (n=8)  (n=9) (n=10)  
∆ T0-T2 +11.6 (2.1) +7.3 (2.0) 0.161 +13.7 (2.0) +6.3 (1.6) 0.011 
∆ T0-T3 +11.3 (2.2) +15.9 (4.7) 0.341 +13.8 (2.0) +12.7 (4.1) 0.819 
ICT (n=15) (n=5)  (n=10) (n=10)  
∆ T0-T2 +15.5 (1.5) +4.4 (2.1) 0.002 +14.8 (1.8) +10.7 (2.8) 0.230 
∆ T0-T3 +18.2 (2.2) +11.4 (5.3) 0.184 +18.3 (2.3) +14.7 (3.7) 0.424 
 
Abbreviations: RAT + FES, Robot Arm Training + Functional Electrical Stimulation; ICT, 
Intensive Conventional Therapy; T0, assessment before treatment; T1, assessment after 3 weeks of 
treatment; T2, assessment after the end of treatment; T3, assessment at 6 months follow-up; p, 
level of significance. 





Assessed for eligibility 
(n=391) 
Excluded  (n=351) 
- Did not meet inclusion criteria (n=341) 
- Other reasons (n=10) 
Analysed  (n=19) 
- Excluded from analysis (n=1) 
Loss to follow-up (n=6) 
- Unable to return after hospital discharge 
(n=4) 
- Medical complications during the 6 months 
follow-up (n=1) 
 
Discontinued intervention (n=1) 
- Medical complications unrelated to 
interventions (n=1) 
Allocated to RAT + FES (n=20) 
- Received allocated intervention (n=19) 
- Did not receive allocated intervention (n=1) 
- Post-randomization drop-out (n=1) 
Loss to follow-up (n=2) 
- Unable to return after hospital discharge 
(n=2) 
 
Discontinued intervention (n=0) 
 
Allocated to ICT (n=20) 
- Received allocated intervention (n=19) 
- Did not receive allocated intervention (n=1) 
- Allocation error (n=1) 
Analysed  (n=20) 
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